{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T10:33:18Z","timestamp":1791369198655,"version":"4.3.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-025-05486-5","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T13:55:34Z","timestamp":1750427734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Critical care illness in allogeneic hematopoietic stem-cell transplantation recipients with chronic graft versus host disease"],"prefix":"10.1186","volume":"29","author":[{"given":"Dara","family":"Chean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romy","family":"Younan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Canet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djamel","family":"Mokart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Platon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Mayaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Wallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahema","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Herl\u00e9","family":"Raphalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"P\u00e8ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Renault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis Peffault","family":"de Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naike","family":"Big\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Lafarge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"5486_CR1","doi-asserted-by":"publisher","unstructured":"Flowers MED, et al. Comparative analysis of risk factors for acute graftversus- host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood. 2011;117(11):3214\u20139. https:\/\/doi.org\/10.1182\/blood-2010-08-302109","DOI":"10.1182\/blood-2010-08-302109"},{"key":"5486_CR2","doi-asserted-by":"publisher","unstructured":"Pidala J, et al. Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patientreported outcomes: a Chronic Graft-versus-Host Disease Consortium study. Haematologica. 2012;97(3):451-8.\u00a0https:\/\/doi.org\/10.3324\/haematol.2011.055186","DOI":"10.3324\/haematol.2011.055186"},{"key":"5486_CR3","doi-asserted-by":"publisher","unstructured":"\u00a0Zeiser R, Blazar BR. Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets. N Engl J Med. 2017;377(26):2565\u201379.\u00a0https:\/\/doi.org\/10.1056\/NEJMra1703472","DOI":"10.1056\/NEJMra1703472"},{"key":"5486_CR4","doi-asserted-by":"publisher","unstructured":"Zeiser R, Blazar BR. Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy. N Engl J Med. 2017;377(22):2167\u201379.\u00a0https:\/\/doi.org\/10.1056\/NEJMra1609337","DOI":"10.1056\/NEJMra1609337"},{"key":"5486_CR5","doi-asserted-by":"publisher","unstructured":"Malard F, Mohty M. Updates in chronic graft-versus-host disease management. Am J Hematol. 2023;98(10):1637\u201344.\u00a0https:\/\/doi.org\/10.1002\/ajh.27040","DOI":"10.1002\/ajh.27040"},{"key":"5486_CR6","doi-asserted-by":"publisher","unstructured":"Kuwatsuka Y, et al. Trends in allogeneic hematopoietic cell transplantation survival using population-based descriptive epidemiology method: analysis of national transplant registry data. Bone Marrow Transplant. 2024;59(9):1295\u2013301.\u00a0https:\/\/doi.org\/10.1038\/s41409-024-02326-y","DOI":"10.1038\/s41409-024-02326-y"},{"key":"5486_CR7","doi-asserted-by":"publisher","unstructured":"D\u2019Souza A, et al. Current Use and Trends in Hematopoietic Cell Transplantation in the United States. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2020;26(8):e177\u2013e82.\u00a0https:\/\/doi.org\/10.1016\/j.bbmt.2020.04.013","DOI":"10.1016\/j.bbmt.2020.04.013"},{"key":"5486_CR8","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/s41409-020-0826-4","volume":"55","author":"JR Passweg","year":"2020","unstructured":"Passweg JR, et al. The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T\u2019s come into focus. Bone Marrow Transplant. 2020;55(8):1604\u201313. https:\/\/doi.org\/10.1038\/s41409-020-0826-4.","journal-title":"Bone Marrow Transpl"},{"key":"5486_CR9","doi-asserted-by":"publisher","unstructured":"Lenglin\u00e9 E, et al. Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2015;50(6):840\u20135.\u00a0https:\/\/doi.org\/10.1038\/bmt.2015.55","DOI":"10.1038\/bmt.2015.55"},{"key":"5486_CR10","doi-asserted-by":"publisher","unstructured":"Lueck C, et al. Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients. Intensive Care Med. 2018;44(9):1483\u201392.\u00a0https:\/\/doi.org\/10.1007\/s00134-018-5347-x","DOI":"10.1007\/s00134-018-5347-x"},{"key":"5486_CR11","doi-asserted-by":"publisher","unstructured":"Lafarge A, et al. Outcomes in Critically Ill Allogeneic Hematopoietic Stem-Cell Transplantation Recipients. Am J Respir Crit Care Med. 2024;210(8):1017\u201324.\u00a0https:\/\/doi.org\/10.1164\/rccm.202401-0135OC.\u00a0","DOI":"10.1164\/rccm.202401-0135OC"},{"key":"5486_CR12","doi-asserted-by":"publisher","unstructured":"Orvain C, et al. Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive Care. Transplantation. 2017;101(2):437\u201344.\u00a0https:\/\/doi.org\/10.1097\/TP.0000000000001143","DOI":"10.1097\/TP.0000000000001143"},{"key":"5486_CR13","doi-asserted-by":"publisher","unstructured":"Pichereau C, et al. Trajectories of acute graft-versus-host disease and mortality in critically ill allogeneic-hematopoietic stem cell recipients: the Allo-GRRR-OH score. Bone Marrow Transplant. 2020;55(10):1966\u201374.\u00a0https:\/\/doi.org\/10.1038\/s41409-020-0857-x","DOI":"10.1038\/s41409-020-0857-x"},{"key":"5486_CR14","doi-asserted-by":"publisher","unstructured":"Lueck C, et al. Impact of chronic graft-versus-host-disease on intensive care outcome in allogeneic hematopoietic stem cell recipients. Bone Marrow Transplant. 2023;58(3):303\u201310.\u00a0https:\/\/doi.org\/10.1038\/s41409-022-01875-4","DOI":"10.1038\/s41409-022-01875-4"},{"key":"5486_CR15","doi-asserted-by":"publisher","unstructured":"Vincent JL, et al. Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: results of a multicenter, prospective study. Working group on \u201csepsis-related problems\u201d of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26(11):1793\u2013800.\u00a0https:\/\/doi.org\/10.1097\/00003246-199811000-00016","DOI":"10.1097\/00003246-199811000-00016"},{"key":"5486_CR16","unstructured":"en France D. D\u00e9c\u00e8s en France - Registre des personnes d\u00e9c\u00e9d\u00e9es en France depuis 1970. Consult\u00e9 le: 14 avril 2023 [En ligne] Disponible sur: https:\/\/www.deces-en-france.fr"},{"key":"5486_CR17","doi-asserted-by":"publisher","unstructured":"Filipovich AH, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2005;11(12):945\u201356.\u00a0https:\/\/doi.org\/10.1016\/j.bbmt.2005.09.004","DOI":"10.1016\/j.bbmt.2005.09.004"},{"key":"5486_CR18","doi-asserted-by":"publisher","unstructured":"Grube M, Holler E, Weber D, Holler B, Herr W, Wolff D. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2016;22(10):1781-91.\u00a0https:\/\/doi.org\/10.1016\/j.bbmt.2016.06.020","DOI":"10.1016\/j.bbmt.2016.06.020"},{"key":"5486_CR19","doi-asserted-by":"publisher","unstructured":"Lenglin\u00e9 E, Mirouse A, Azoulay E. Top ten tips for the management of critically ill hematopoietic stem cell transplantation recipients. Intensive Care Med. 2019;45(3):384\u20137. https:\/\/doi.org\/10.1007\/s00134-019-05587-0","DOI":"10.1007\/s00134-019-05587-0"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05486-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05486-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05486-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T13:55:36Z","timestamp":1750427736000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-025-05486-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5486"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05486-5","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethical committee of the French Intensive Care Society.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EC has received lecturer and conference-speaker fees, as well as reimbursements of travel and accommodation expenses related to attending scientific meetings, from Gilead, Shionogi, and Sanofi-Genzyme. LZ reports receiving fees for lectures for MSD and Sanofi and her institution received a research grant from Jazz Pharmaceuticals. EA has received fees for lectures from Gilead, Baxter, and Alexion.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":".","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"257"}}